By Jack Costa
Members of the immunocompromised community, like for many other groups encompassed by the disability community, are presented with unique challenges to inclusion and accommodation. Those affected by a primary immunodeficiency (e.g., Common Variable Immune Deficiency, Severe Combined Immunodeficiency, X-Linked Agammaglobulinemia) and/or affected by a compromised immune system for external reasons (e.g., as a result of taking immunosuppressant medications) are often at a high risk for severe infection and hospitalization upon exposure to common illnesses. It falls on the individual to make a calculated risk assessment for participation in every facet of regular life, including predicting whether activities would be too high-risk to partake in (i.e., there being a high chance of exposure to illnesses) while also assessing whether some activities are important enough to risk the possibility of exposure. While immunocompromised individuals try to control this to the best of their ability, their health is chiefly dictated by the actions of others. Whether “healthy” people choose to engage in sanitary practices, act responsibly when sick, and accommodate/adjust their actions for the vulnerable directly affects the immunocompromised community’s ability to be active participants in daily life. For this reason, it is very difficult to legislate solutions to accessibility issues for the immunocompromised, as this would have to regulate and scrutinize the actions of a large sum of “healthy” individuals for the benefit of a small vulnerable community. The legislative agenda for immunocompromised advocacy groups normally focuses on issues that would curb barriers to affordable care and improve some conditions for at-risk individuals (e.g., vaccine policy), but these ultimately do not address the core problems that prevent justice for the immunocompromised community and instead intend to mitigate risk/harm in light of an inaccessible world. A dramatic social shift might be the only way for true justice to be achieved.
While it can be argued that disability legislation benefits all, not just the disability community, this may not be perceived as true of policy that would fundamentally address the needs of the immunocompromised community. This was evident in the COVID-19 pandemic era. This was a very unique time period, as all communities were exposed to a perspective and required level of risk-analysis that the immunocompromised community deals with on an everyday basis. Throughout the world, governmental policies and societal measures that intended to address the spreading and containment of disease often involved lockdowns, quarantines for the ill, social-distancing, masking, vaccine mandates, and specific sanitary procedures. In the United States, for instance, there was a substantial social backlash by many as a result of perceived governmental overreach in these measures (and this was during a period when the risk of infection affected all and not just the immunocompromised). While implementation of some of these precautions could definitely still be considered beneficial to all people, even not in times of crisis like a global pandemic (e.g., maintaining strict sanitation and disinfection protocols), the widespread negative social response to a more restrictive lifestyle during this time period reflected a general dissatisfaction that many would likely display if required to concern themselves with the needs of at-risk individuals on a day-to-day basis. This may make disability justice appear out of reach for the immunocompromised community, but social change is always possible.
At the state and federal level, there are a lot of key policy issues that organizations like the Immune Deficiency Foundation are actively advocating for to promote a more equitable world for the immunocompromised community. In their federal lobbying Advocacy Day in D.C. in May 2025, their primary points of emphasis were:
Many immunocompromised patients rely on Medicaid coverage to receive life-saving antibody replacement medication and may have barriers to work or difficulty meeting other requirements proposed in the One Big Beautiful Bill Act (2025) as means to limit federal health care coverage.
Breakthroughs in treatment options for primary immunodeficiencies (PIs) have been spearheaded by institutions and programs dependent on federal funding. Since no clear cure currently presents itself for the most common forms of PI, the community relies on the prospect of scientific advancements to improve treatment options and eventually lead to larger developments.
Many immunocompromised individuals do not produce an immune response to certain vaccinations, implying they cannot receive the same level of protection as others who receive the same vaccination. For this reason, it remains a constant goal of the immunodeficient community to advocate for pro-vaccine policies, as “healthy” individuals’ vaccine rates remain vital to the safety of those who cannot receive protection from immunization.